KPV.

KPV is a C-terminal tripeptide of alpha-MSH (Lys-Pro-Val) and anti-inflammatory peptide. With the molecular formula C₁₈H₃₃N₅O₄ and a molecular weight of 383.5 g/mol (CAS: 17750-43-5), it presents a we...

$36.00

Select Protocol

Lab Verified

Clinical Grade

PMID Cited

Mechanism of Action.

Published preclinical research has characterized the following molecular pathways and receptor interactions for KPV.

Receptor interaction

NF-κB Pathway

Published research demonstrates KPV modulates targeted signaling cascades within cell tissue models.

Signaling cascade

Intestinal epithelial signaling

In cellular environments, KPV exhibits selective binding and corresponding pathway activation.

Evidence Based

Clinical Literature

View All Studies

Preclinical

Research review on KPV molecular characterization.

Preclinical studies have characterized the molecular properties and receptor binding profiles of KPV in standardized assay systems.

Preclinical

KPV structure-activity relationship analysis.

Structure-activity relationship studies have examined the functional domains and binding characteristics of KPV in cell-free and cell-based systems.

RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.

Continue Exploring